Movado Group reported Q3 2026 earnings with 3.1% revenue growth, improved gross margins, and increased net income. The company saw strong performance in US markets, fashion brands, and direct-to-consumer channels, with optimism about watch category dynamics among younger consumers.

Taylor Swift's engagement announcement triggered a brief stock market surge for jewelry companies, with Signet Jewelers and Brilliant Earth Group experiencing notable price increases due to fan interest and potential wedding ring searches.

Movado Group reported Q2 fiscal 2026 results with a 3.1% sales increase to $161.8 million and doubled adjusted operating profit to $7 million, navigating challenges from U.S. tariffs on Swiss imports through strategic inventory management and cost reductions.

Movado Group reported Q2 fiscal 2026 results with 3.1% sales growth to $161.8 million, doubled operating profit, and navigating challenges from U.S. tariffs on Swiss watch imports while focusing on strategic brand initiatives and cost management.

Rosen Law Firm, a global investor rights law firm, reminds purchasers of Sana Biotechnology, Inc. (NASDAQ: SANA) securities between March 17, 2023 and November 4, 2024 of the important May 20, 2025 lead plaintiff deadline in a securities class action lawsuit.

Rosen Law Firm announces a securities class action lawsuit against Perpetua Resources Corp. (PPTA) for allegedly providing investors with material information concerning the expected initial capital expenditure for the Stibnite Gold Project, while disseminating false and misleading statements about the true cost of the project.

Movado Group, Inc. (NYSE: MOV) disclosed allegations of misconduct within its Dubai branch, resulting in an overstatement of sales, premature recognition of sales, and underreporting of credit notes. The company's financial statements from 2022 require restatement, and its internal controls were found to be ineffective.

UnitedHealth Group's stock fell 22.3% on April 17, 2025, after the company's earnings fell short of expectations and it downgraded its projected results for 2025 due to problems in its Medicare business.

Movado Group, Inc. revealed that its former Dubai branch manager and certain employees engaged in misconduct, resulting in an overstatement of sales and premature recognition of revenue over a five-year period. The company's financial statements for fiscal years 2022-2024 require restatement, and a material weakness in internal controls was identified.

The article discusses three stocks that offer long-term passive income potential: Altria Group (MO), Movado Group (MOV), and LyondellBasell Industries (LYB). These companies have reliable cash flows, high dividend yields, and resilience to market volatility.

Movado Group's stock fell nearly 15% after the company reported weaker-than-expected Q2 results, with net sales and net income declining year-over-year. The company also revised its full-year guidance downward.

Shares of Titan Machinery Inc. (NASDAQ: TITN) moved lower during Thursday’s trading following weak quarterly results. Titan Machinery posted quarterly earnings of $1.32 per share, missing market estimates of $1.53 per share. The company’s quarterly sales came in at $694.12 million versus estimates of $727.20 million. Titan Machinery shares declined 8.1% to $23.41 on Thursday. Here are some other stocks moving in today's mid-day session. Gainers Minim Inc (NASDAQ: MINM) shares jumped 700% to $7.36 after gaining over 13% on Wednesday. AgriFORCE Growing Systems Ltd. (NASDAQ: AGRI) gained 174% to $2.47. Soligenix, Inc. (NASDAQ: SNGX) surged 116% to $0.90 after the company announced it received FDA IND clearance for the Phase 2 clinical trial of dusquetide in the treatment of aphthous ulcers of Behçet's disease. ImmunoGen, Inc. (NASDAQ: IMGN) shares jumped 80% to $28.89 after AbbVie announced it will acquire the company in a transaction valued at $31.26 per share in cash. Smart for Life, Inc. (NASDAQ: SMFL) gained 46% to $2.2221. Aditxt, Inc. (NASDAQ: ADTX) shares climbed 45% to $5.00. REX American Resources Corporation (NYSE: REX) gained 30.7% to $48.22 following strong third-quarter results. Clearmind Medicine Inc. (NASDAQ: CMND) rose 24.2% to $5.03 after surging 22% on Wednesday. Clearmind Medicine recently announced results from its weight loss and metabolic disorder program. Ucommune International Ltd (NASDAQ: UK) gained 21.8% to $6.58. Ampio Pharmaceuticals, Inc. (NASDAQ: AMPE) shares surged 21% to $2.3750 ...